Concepedia

Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma

Chunyan Xue, Yingying Huang, Pei Huang, Jianji Pan, Longzhong Liu, Xiaoling Song, S. Lin, Jun Wu, J. W. Zhang, Hong Zhao,

Annals of Oncology · 2012 · 91 citations · 36 references

DOIFull text

Open access

Concepts

References

36

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

Martin Reck, Joachim von Pawel, Petr Zatloukal et al. · Journal of Clinical Oncology · 2009 · 1.5K citations

, , +13

Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group

Michael K. Gibson, Yi Li, Barbara A. Murphy et al. · Journal of Clinical Oncology · 2005 · 494 citations

, , +14

Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Silvia Novello, Joachim von Pawel et al. · Journal of Clinical Oncology · 2010 · 454 citations · Full text

, , +17